We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Omega Diagnostics Group Plc | LSE:ODX | London | Ordinary Share | GB00B1VCP282 | ORD 4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 2.20 | 2.00 | 2.40 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
23/10/2020 11:47 | I knew it would work... (some people have clearly had a sense of humour by-pass...) | control1 | |
23/10/2020 11:45 | strange they only delayed it by 5 or so minutes, would normally see it after hours! | jusjusjus | |
23/10/2020 11:40 | 100000 buy just gone through Looks like seller cleared Perfect storm | michael boyle1 | |
23/10/2020 11:40 | If it takes 90 days and we are almost at that point then what does that tell you about the govts urgency on this. https://mhrainspecto | 68sjb7g | |
23/10/2020 11:37 | ant - yeah, I was leaning more towards Monday, FOMO before lunchtime would tend to agree with us as well | jusjusjus | |
23/10/2020 11:35 | Jus I think we will see this Monday or Tuesday CK has been quite clever about the way he has timed his presentations. | ant15 | |
23/10/2020 11:29 | Someone noted on Twitter that the presentation from Colin next Wednesday (28th) is exactly 90 days from the MHRA submission, would be a bit of a coup to announce that (if it doesn't arrive next Monday/Tuesday) | jusjusjus | |
23/10/2020 11:22 | Here we go | michael boyle1 | |
23/10/2020 11:21 | FOMO Friday starting a bit earlier this week, still don't understand some selling into it! | jusjusjus | |
23/10/2020 09:37 | As a holder of NCYT and TLW, this is now my lame duck share...! | control1 | |
23/10/2020 09:21 | It feels like NCYT is the only covid stock | teamwork1 | |
22/10/2020 23:20 | https://www.dailymai | ayl30 | |
22/10/2020 21:48 | Buddy one. Coming from the local area and a long time supporter of the festival. Personally I think even with tests it would be wholly irresponsible to hold it in it's current form until a vaccine is available. Due to it now being s global event. | upomega | |
22/10/2020 21:21 | https://twitter.com/ | craig bulb | |
22/10/2020 21:21 | Tests 1 million plus a week via moonshot which odx provide minimum of 25% and antigen tests let alone antibody tests it says it all in video | craig bulb | |
22/10/2020 21:20 | Nxc You've hit the nail on the head. Gvnt for some bizarre reason is not promoting GB in terms of diagnostics and their tests. The big question is as to why. This is either a deliberate ploy on their part or alternatively the other tests are better .Maybe that is now the problem with as to why the share price is not moving . Together with elusive contracts which only we only seem to hear about via Twitter . In other words as investors one must ask the question.Who do we trust and believe in . Gvnt or company.Only my view on matters. | upomega | |
22/10/2020 21:15 | https://twitter.com/ | craig bulb | |
22/10/2020 20:43 | Next year will be interesting: Glastonbury Festival 2021: Revellers could be tested for coronavirus three times, Michael Eavis suggests "There could be massive testing arrangements" At Wells Festival of Literature on Wednesday (October 21) Mr Eavis spoke about Covid-19 testing that could be put in place at the festival. He said: "Next year, we are not sure about, but the testing is going so well now. There could be massive testing arrangements. That is 200,000 revellers x 3 at one festival...... | buddy one | |
22/10/2020 20:29 | The frustrations I have highlighted are across the industry and are not specifically related to either of the companies you mention Barry - the problem also is that the smell of money is corrosive in terms of doing what is right - if you are a member of the RTC are you really going to complain that the guy in charge is a Bellend ? Therein lies the moral dilemma of benefiting from the Chumocracy and Crony Capitalism - reminds of Groucho Marx and his principles quote. One really despairs when you see the Government awarding a £138m contract to Inova for a lateral flow antigen test that effectively only works on swabs when the whole thrust has been to use saliva - a number of people I have spoken to believe rightly or wrongly that a lot of this stuff is routed through Cummings. | nxc | |
22/10/2020 19:37 | Then perhaps Omega or Abingdon should voice their frustrations on radio or TV... | barrywhit | |
22/10/2020 19:36 | Zulu . And who do you think would do a better job than old Boris then. | scaff55 | |
22/10/2020 19:36 | nxc I think it now needs your good self together with ceos,s from the uk diagnostic industry to lobby parliament. I still do not understand why Nicola Sturgeon is not all over this. | upomega | |
22/10/2020 19:30 | nxc, Boris' moonshot money is being wasted on the ridiculously useless track and trace system that Germany showed them months ago centralising didn't work. Colin has positioned the company excellently but as you have said, Boris and his big pharma cronies are overlooking the UK companies although he said he wanted to build the UK diagnostics industry up. The whole pandemic has been a disaster from the start with poor strategy. Heading for full lockdown as people not following the rules and no wonder with Boris in charge. ODX will come good and sure we will be running at full capacity as we should be as it is a serious situation for the world with this pandemic. | zuludave77 | |
22/10/2020 19:16 | The dam will eventually break at some point - the level of incompetence within Government is breathtaking - the Cabinet as a whole are focused time wise on Brexit and the key decisions on diagnostic testing are being taken lower down the food chain by people who have no diagnostic experience. I think as a consequence there is no real leadership and no one that can corral all the relevant agencies in the same direction. A good example is the MHRA looking for extended stability data - at this stage of the game three months is enough given the tests will be used almost as soon as they are manufactured. It is this type of nonsense that is holding thinks back. Additionally PHE are beyond redemption in terms of their evaluations - I have received several reports of failed evaluations where basically PHE have been unable to follow basic instructions. A further delay in progressing validation is access to clinical samples - a clear uneven playing field if ever there was one and where the Oxford cabal is dominant. Some of the stuff you could not make up - however at some point the dam will break as there is a clear gearing up of capacity right across the board in both antigen and antibody testing - the general view is that they have a plan but do not want to are it visible until they know they can execute against it. Patience remains a virtue. The good thing for ODX is that Colin and his team have placed themselves right at the centre of lateral flow antibody and antigen testing in conjunction with a multiple partner strategy. | nxc | |
22/10/2020 16:29 | and mologic antigen? wtf | remarkomsoc |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions